A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis

Allergy and Asthma Proceedings

Volumn 26, Issue 6, 2005, Pages 470-476

  Castro, Henry J ^a   Mendez Inocencio, Julia I ^a   Omidvar, Berna ^a   Omidvar, Jemal ^a   Santilli, John ^a   Nielsen Jr , H S ^b   Pavot, Alfred P ^c   Richert, John R ^a   Bellanti, Joseph A ^a,d  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Allermed Laboratories Inc   (United States)

^c Greater Southeast Community Hospital   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEE VENOM; IMMUNOGLOBULIN E;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SKIN TEST; TREATMENT OUTCOME;

ADULT; BEE VENOMS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; SKIN TESTS; TREATMENT OUTCOME;

EID: 30844449630     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lublin FD, and Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology 46:907-911, 1996.
2. Braunwald E, Fauci A, Kasper D, et al. (Eds). Harrison's Principles of Internal Medicine Textbook. New York: McGraw-Hill, 2001.
3. Fisher RB. Bee venom and chronic inflammatory disease. N Z Med J 9:639, 1986.
4. Kang SS, Pak SC, and Choi SH. The effect of whole bee venom on arthritis. Am J Clin Med 30:73-80, 2002.
5. Somerfield SD. Bee venom and adjuvant arthritis. J Rheumatol 10:522, 1983.
6. Beck B. The Bible of Bee Venom Therapy. New York: Appleton-Century, 1935. 1-238.
7. Yoirish N. The Curative Properties of Honey and Bee Venom. San Francisco: New Glide Publications, 1977.
8. Hadjipetrou-Kourounakis L, and Yiangou M. Bee venom and adjuvant induced disease. J Rheumatol 11:720, 1984.
9. Hadjipetrou-Kourouiiakis L, and Yiangou M. Bee venom, adjuvant induced disease and interleukin production. J Rheumatol 15:1126-1128, 1988.
10. Portnoy JM, Moffitt JE, Golden DB, et al. Stinging insect hypersensitivity: A practice parameter. The Joint Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 103:963-980, 1999.
11. Li JT, Lockey RF, Bernstein IL, et al. (Eds). Joint Task Force on Practice Parameters. Allergen immunotherapy: A practice parameter. American Academy of Allergy. Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 90:1-40, 2003.
12. Hsiang HK, and Elliott WB. Differences in honey bee (Apis mellifera) venom obtained by venom sac extraction and electrical milking. Toxicon 13:145-148, 1975.
13. Li KC, and Chen J. Altered pain-related behaviors and spinal neuronal responses produced by sq injection of melittin in rats. Neuroscience 126:753-762, 2004
14. Kemeny DM, Dalton N, Lawrence AJ, et al. The purification and characterization of hyaluronidase from the venom of the honey bee, Apis mellifera. Eur J Biochem 139:217-223, 1984.
15. Owen MD. The venom system and venom hyaluronidase of the African honey bee (Apis mellifera adansonii) Toxicon 21:171-174, 1983.
16. Nam KW, Je KH, Lee JH, et al. Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1 beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom. Arch Pharm Res 26:383-388, 2003.
17. Santilli J, Rockwell WJ, Wallerstedt DB, and Bellanti JA. The use of honeybee venom therapy as a treatment in chronic progressive multiple sclerosis - A case report. Ann Allergy Asthma Immunol 82:123, 1999.
18. Panush RS. Controversial arthritis remedies. Bull Rheum Dis 34:1-10, 1984.
19. Locksliin MD. Special article: The unproven remedies committee. Arthritis Rheum 24:1188-1190, 1981.
20. Panush RS, and Longley S. Therapies of potential but unproven benefit. In Rheumatoid Arthritis: Etiology, Diagnosis. Utsinger PD, Zvaifler NJ, Ehrlich GE (Eds). Philadelphia: Lippincott, 1985.
21. Panush RS. Nontraditional remedies. In Primer on Rheumatic Diseases, 9th ed. Schumacher HR (Eds). Atlanta: Arthritis Foundation. 1988.
22. Panush RS. Honeybee and arthritis: Sharpening prospective on a sticky issue. J Rheumatol 15:1461-1462, 1988.